Anixa Biosciences
ANIX
ANIX
49 hedge funds and large institutions have $15.4M invested in Anixa Biosciences in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
10% less capital invested
Capital invested by funds: $17.1M → $15.4M (-$1.73M)
Holders
49
Holding in Top 10
–
Calls
$194K
Puts
$25K
Top Buyers
| 1 | +$132K | |
| 2 | +$128K | |
| 3 | +$119K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$106K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$96.5K |
Top Sellers
| 1 | -$178K | |
| 2 | -$52.8K | |
| 3 | -$39.6K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$15.4K |
| 5 |
BlackRock
New York
|
-$14K |